盐酸氨溴索加盐酸丙卡特罗治疗小儿肺炎的临床观察  

Clinical observation of ambroxol hydrochloride plus procaterol hydrochloride in the treatment of pneumonia in children

在线阅读下载全文

作  者:苟亚冰 徐小云 Gou Yabing;Xu Xiaoyun(Longxian Traditional Chinese Medicine Hospital,Baoji,Shaanxi 721200,China;Longxian Maternal and Child Health Hospital,Baoji,Shaanxi 721200,China)

机构地区:[1]陕西省陇县中医医院,陕西宝鸡721200 [2]陕西省陇县妇幼保健院,陕西宝鸡721200

出  处:《首都食品与医药》2024年第8期57-60,共4页Capital Food Medicine

摘  要:目的分析治疗小儿肺炎采用盐酸氨溴索加盐酸丙卡特罗干预后的临床效果。方法试验开展时间在2021年11月-2022年12月之间,共纳入符合试验要求的研究对象90例,结合患儿住院时间进行组别类目划分,并借助加强组(实施盐酸氨溴索加盐酸丙卡特罗干预治疗)及基础组(采用常规肺炎治疗方法进行干预)表示组别类目,将干预后治疗总有效率、患儿多个临床症状改善时间、用药后不良反应发生率及各项生活质量评分进行组间数据对比。结果干预后:加强组患儿治疗总有效率优于基础组,P<0.05;治疗后加强组与基础组患儿咳嗽消退时间、退热时间及肺部啰音消失时间进行组间数据对比,显示较大的对比差异,P<0.05;用药后加强组患者总不良反应发生率显著低于基础组,P<0.05;干预后加强组患者各项生活质量评分优于基础组,P<0.05。结论采用盐酸氨溴索加盐酸丙卡特罗治疗小儿肺炎,可显著缩短患儿各个临床症状消退时间,同时提升治疗总有效率,而且在治疗过程中不良反应发生率也有所降低,整体干预效果显著,值得广泛推广与应用。Objective To analyze the clinical effect of ambroxol hydrochloride plus procatracan hydrochloride in the treatment of pediatric pneumonia.Methods The experiment was carried out from November 2021 to December 2022.A total of 90 patients meeting the experimental requirements were included in this experiment,and the groups were divided into categories based on the length of hospitalization of pediatric patients.The enhanced group(ambroxol hydrochloride plus procaterol hydrochloride intervention treatment)and the basic group(intervention with conventional pneumonia treatment)were used to represent the groups and categories.The effective rate of treatment after intervention,the improvement time of multiple clinical symptoms in children,the incidence of adverse events after medication and various quality of life scores were compared between groups.Results After intervention,the total effective rate index of the enhanced group was better than that of the basic group,P<0.05;after treatment,the data of cough resolution time,fever regression time and lung rales disappearance time were compared between the enhanced group and the basic group,which showed great difference(P<0.05).The incidence of total adverse conditions in the enhanced group was significantly lower than that in the basic group,P<0.05;after intervention,the scores of quality of life in the enhanced group were better than those in the basic group(P<0.05).Conclusion After the intervention of ambroxol hydrochloride and procatterol hydrochloride in the treatment of pediatric pneumonia,the time for each clinical symptom to resolve is significantly shortened,the total effective rate of treatment is improved,and the incidence of adverse conditions is also effectively reduced in the treatment process.The overall intervention effect is significant,worthy of widespread promotion and application.

关 键 词:盐酸氨溴索 盐酸丙卡特罗 治疗 小儿肺炎 

分 类 号:R725.6[医药卫生—儿科]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象